Found: 16
Select item for more details and to access through your institution.
Neither inflammatory bowel disease nor immunosuppressants are associated with an increased risk of severe COVID-19: an observational Dutch cohort study.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 465, doi. 10.1007/s10238-021-00755-3
- By:
- Publication type:
- Article
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 477, doi. 10.1007/s10238-021-00771-3
- By:
- Publication type:
- Article
High levels of Von Willebrand factor markers in COVID-19: a systematic review and meta-analysis.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 347, doi. 10.1007/s10238-021-00769-x
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of idiopathic membranous nephropathy with glomerular IgM deposits.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 455, doi. 10.1007/s10238-021-00768-y
- By:
- Publication type:
- Article
Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseases.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Clinical features and outcomes of anti-neutrophil cytoplasmic autoantibody-associated vasculitis in Chinese childhood-onset patients.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 447, doi. 10.1007/s10238-021-00762-4
- By:
- Publication type:
- Article
PEAK1 promotes invasion and metastasis and confers drug resistance in breast cancer.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 393, doi. 10.1007/s10238-021-00761-5
- By:
- Publication type:
- Article
Effectiveness of methylprednisolone therapy in patients with a high-risk common type of COVID-19 pneumonia: a retrospective cohort study.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 487, doi. 10.1007/s10238-021-00765-1
- By:
- Publication type:
- Article
Factors associated with the antinuclear antibody (ANA) titer of systemic autoimmune rheumatic diseases in ANA-positive patients after treatment: a retrospective study.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 439, doi. 10.1007/s10238-021-00759-z
- By:
- Publication type:
- Article
Association between complement gene polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 427, doi. 10.1007/s10238-021-00758-0
- By:
- Publication type:
- Article
miR-522 regulates cell proliferation, migration, invasion capacities and acts as a potential biomarker to predict prognosis in triple-negative breast cancer.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 385, doi. 10.1007/s10238-021-00757-1
- By:
- Publication type:
- Article
Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 421, doi. 10.1007/s10238-021-00756-2
- By:
- Publication type:
- Article
FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 371, doi. 10.1007/s10238-021-00760-6
- By:
- Publication type:
- Article
Programmed cell death-ligand 1 (PD-L1)<sup>+</sup> tumour cells and low-reacting programmed cell death 1 (PD1)<sup>+</sup> tumour-infiltrating lymphocytes predict poor prognosis in Epstein–Barr virus<sup>+</sup> diffuse large B-cell lymphoma.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 411, doi. 10.1007/s10238-021-00754-4
- By:
- Publication type:
- Article
Cortactin and HER2 as potential markers for dural-targeted therapy in advanced gastric cancer.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 403, doi. 10.1007/s10238-021-00752-6
- By:
- Publication type:
- Article
COVID-19-associated opportunistic infections: a snapshot on the current reports.
- Published in:
- Clinical & Experimental Medicine, 2022, v. 22, n. 3, p. 327, doi. 10.1007/s10238-021-00751-7
- By:
- Publication type:
- Article